Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABHD16A | O95870 | 2/20 | 0.54 |
| ▸ | MGLL | Q99685 | 4/20 | 0.53 |
| ▸ | FAAH | O00519 | 3/20 | 0.53 |
| ▸ | LPL | P06858 | 1/20 | 0.49 |
| ▸ | LIPC | P11150 | 1/20 | 0.49 |
| ▸ | LIPE | Q05469 | 1/20 | 0.49 |
| ▸ | GPR52 | Q9Y2T5 | 1/20 | 0.39 |
| ▸ | ABHD6 | Q9BV23 | 1/20 | 0.39 |
| ▸ | NNMT | P40261 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6551089 | 0.84 | ABHD16A (0.67) | ABHD16AMGLLFAAHLPLLIPC | |
| SCHEMBL7043178 | 0.82 | ABHD16A (0.59) | ABHD16AMGLLFAAHLPLLIPC | |
| SCHEMBL7571649 | 0.79 | MGLL (0.72) | ABHD16AMGLLFAAHLPLLIPC | |
| SCHEMBL7046511 | 0.77 | ABHD16A (0.57) | ABHD16AMGLLFAAHLPLLIPC | |
| SCHEMBL7045989 | 0.76 | MGLL (0.66) | ABHD16AMGLLFAAHLPLLIPC | |
| SCHEMBL7046507 | 0.76 | ABHD16A (0.56) | ABHD16AMGLLFAAHLPLLIPC | |
| SCHEMBL7048013 | 0.75 | ABHD16A (0.65) | ABHD16AMGLLFAAHLPLLIPC | |
| SCHEMBL6604642 | 0.74 | LPL (0.62) | ABHD16AMGLLFAAHLPLLIPC | |
| SCHEMBL7046228 | 0.74 | ABHD16A (0.72) | ABHD16AMGLLFAAHLPLLIPC | |
| SCHEMBL7656723 | 0.74 | MGLL (0.62) | ABHD16AMGLLFAAHLPLLIPC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1263745-B1 | SUBSTITUTED 3-PHENYL-5-ALKOXI-1,3,4-OXDIAZOL-2-ONE AND USE THEREOF FOR INHIBITING HORMONE-SENSITIVE LIPASE | AVENTIS PHARMA GMBH (DE) | 2004-05-19 | — | — | EP | disclosed |